You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 21, June 2, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Presymptomatic Diagnosis of Delayed-Onset Disease With Linked DNA Markers

The Experience in Huntington's Disease

Jason Brandt, PhD; Kimberly A. Quaid, PhD; Susan E. Folstein, MD; Paul Garber; Nancy E. Maestri, PhD; Margaret H. Abbott, RN, MPH; Phillip R. Slavney, MD; Mary L. Franz, MSW; Laura Kasch; Haig H. Kazazian, Jr, MD

JAMA. 1989;261(21):3108-3114.


Abstract

Clinical medicine in the 21st century is almost certain to include wide-scale use of molecular genetic diagnostic tests. In September 1986, The Johns Hopkins University School of Medicine initiated a voluntary program of presymptomatic genetic testing for Huntington's disease for persons at 50% risk. DNA analyses using the D4S10 (G8), D4S43, and D4S95 locus probes have been performed for 55 people. Twelve of the tests have yielded positive results, 30 were negative, and 13 were uninformative. Initial reactions ranged from joy and relief to disappointment, sadness, and demoralization. Thus far, there have been no severe depressive reactions. Although the sample size is small, our data suggest that people who receive genetic test results cope well, at least over the short term, when the testing is performed in a clinical context that includes education, pretest counseling, psychological support, and regular follow-up.

(JAMA. 1989;261:3108-3114)



Author Affiliations

From the Departments of Psychiatry and Behavioral Sciences (Drs Brandt, Quaid, Folstein, and Slavney, Mr Garber, and Mss Abbott and Franz) and Pediatrics (Dr Kazazian and Ms Kasch), The Johns Hopkins University School of Medicine, and The Johns Hopkins University School of Hygiene and Public Health (Dr Maestri), Baltimore, Md. Dr Maestri is now in the Division of Human Genetics, University of Maryland School of Medicine, Baltimore.


Footnotes

Reprint requests to the Department of Psychiatry and Behavioral Sciences, Meyer 218, The Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21205 (Dr Brandt).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review
Timman et al.
J. Med. Genet. 2004;41:e100-e100.
ABSTRACT | FULL TEXT  

"Genetic Exceptionalism" in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests
Green and Botkin
ANN INTERN MED 2003;138:571-575.
ABSTRACT | FULL TEXT  

Psychological studies in Huntington's disease: making up the balance
Duisterhof et al.
J. Med. Genet. 2001;38:852-861.
FULL TEXT  

Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium
Harper and Lim
J. Med. Genet. 2000;37:567-571.
ABSTRACT | FULL TEXT  

Neuropsychiatric Correlates and Treatment of Lenticulostriatal Diseases: A Review of the Literature and Overview of Research Opportunities in Huntington's, Wilson's, and Fahr's Diseases
ANPA Committee on Research et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:249-266.
ABSTRACT | FULL TEXT  

Patients' Attitudes Toward Detection of Heterozygous Familial Hypercholesterolemia
Andersen et al.
Arch Intern Med 1997;157:553-560.
ABSTRACT  

Huntington's Disease: Lessons from and for Molecular Neuroscience
Young
Neuroscientist 1995;1:51-58.
ABSTRACT  

A Worldwide Study of the Huntington's Disease Mutation: The Sensitivity and Specificity of Measuring CAG Repeats
Kremer et al.
NEJM 1994;330:1401-1406.
ABSTRACT | FULL TEXT  

Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene: Relevance for Other Adult-Onset Disorders
Babul et al.
JAMA 1993;270:2321-2325.
ABSTRACT  

Molecular Genetics of Huntington's Disease
Gusella et al.
Arch Neurol 1993;50:1157-1163.
ABSTRACT  

Molecular Medicine: A Spin-off From the Helix
Caskey
JAMA 1993;269:1986-1992.
ABSTRACT  

Are There Neuropsychologic Manifestations of the Gene for Huntington's Disease in Asymptomatic, At-Risk Individuals?
Strauss and Brandt
Arch Neurol 1990;47:905-908.
ABSTRACT  

Insurance and the Presymptomatic Diagnosis of Delayed-Onset Disease
Quarrell et al.
JAMA 1989;262:2384-2385.
ABSTRACT  

PSYCHOLOGICAL EFFECT OF GENETIC SCREENING FOR HUNTINGTON'S DISEASE
JWatch General 1989;1989:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.